Chakraborty, Rajput’s girlfriend, has alleged that a manufactured prescription was used to help him acquire drugs prohibited by the Narcotics and Psychotropic Substances Act just days before his suicide in June 2020.
“The allegations in this FIR are mostly presumed and speculative in nature,” the CBI said.
The Central Bureau of Investigation also noted that it is investigating the complaint made by Rajput’s father, KK Singh, against Rhea and her family members for allegedly instigating the 34-year-old actor’s suicide.
The Rajput sisters filed the petition through lawyer Madhav Thorat on October 6 seeking to have the FIR filed against them by the Bandra police annulled.
According to CBI, the police should have carried out a preliminary investigation before registering the First Information Report (FIR).
“It is an established law that two FIRs cannot be registered for the same cause of action … the IWC is already investigating the causes related to the death of Sushant Singh Rajput and all aspects surrounding it.
“In view of this, it was expected that the Mumbai police would forward the complaint received from Rhea Chakraborty to the CBI instead of registering the FIR,” the CBI said.
“Therefore, the FIR’s registration of the same facts and cause of action is unjustified and not allowed by law. Therefore, this FIR is flawed and bad under the law,” the agency said.
If Rhea Chakraborty was aware of the mobile phone chat between Rajput and her sister Priyanka in June 2020 during which Priyanka allegedly sent her a prescription, then Rhea should not have kept silent until September, the CBI said.
He was conducting an investigation without being hampered by any outside factor in an impartial manner, he said.
The police FIR names the two Rajput sisters and a doctor from Ram Manohar Lohia Hospital in Delhi, Tarun Kumar, who allegedly signed the prescription.
The HC will hear the petition on November 4.
.
